
|Articles|May 15, 2003
ICL effective treatment for moderate, high hyperopia
Author(s)Julia Talsma
San Francisco-At 1-year follow-up, the majority of patients who received the hyperopic Implantable Contact Lens (ICL, STAAR Surgical, Monrovia, CA) for correction of moderate to high hyperopia were satisfied with an uncorrected visual acuity (UCVA) of at least 20/40 or better, noted Paul J. Dougherty, MD, who spoke during the American Society of Cataract and Refractive Surgery Annual Meeting.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Glaucoma 2026: Which emerging technologies will change practice?
2
How AI is reshaping ophthalmology in 2025 and beyond
3
Molecular insights and clinical experience: Extending anti-VEGF durability
4
8 things to know about aflibercept 8 mg for retinal vascular disease
5












































